Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2096674 Target Snapshot

Cyclooxygenase · PROTEIN FAMILY · Bos taurus

284Compounds
29Assays
5Approved Drugs
177.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt O62664. Use UniProt O62664 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt O62664 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Cyclooxygenase as ChEMBL target CHEMBL2096674, mapped to UniProt O62664. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Cyclooxygenase
PROTEIN FAMILY · Bos taurus
As of 2026-09-13
ChEMBL target ID
CHEMBL2096674
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
O62664
Prostaglandin G/H synthase 1
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Cyclooxygenase is the right protein anchor across sources, using UniProt O62664 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelProstaglandin G/H synthase 1
UniProt AccessionO62664
Component TypeProtein
Sequence Length600 aa

Prostaglandin G/H synthase 1

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Cyclooxygenase, mapped to UniProt O62664. ChEMBL maps the protein component as Prostaglandin G/H synthase 1. Sequence length is 600 aa.

Mapped IDO62664
Review nameCyclooxygenase
OrganismBos taurus
Clinical Profile

Clinical Phase Distribution

5
Approved
1
Phase III
4
Phase II
Assay Mix

Activity Type Distribution

IC50177.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL432463 8.1 IC50 8.0 Preclinical
CHEMBL6 7.96 IC50 11.0 Approved
CHEMBL28976 7.7 IC50 20.0 Preclinical
CHEMBL28507 7.7 IC50 20.0 Preclinical
CHEMBL28508 7.7 IC50 20.0 Preclinical
CHEMBL281012 7.52 IC50 30.0 Preclinical
CHEMBL292239 7.52 IC50 30.0 Preclinical
CHEMBL29047 7.4 IC50 40.0 Preclinical
CHEMBL538408 7.3 IC50 50.0 Preclinical
CHEMBL418035 7.3 IC50 50.0 Preclinical
Distribution

pChEMBL Value Distribution

9
5.0
17
5.5
20
6.0
11
6.5
14
7.0
7
7.5
1
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

BROMFENAC SODIUM
CHEMBL3181947
Approved 1997
INDOMETHACIN
CHEMBL6
Approved 1965
Assay Landscape

Assay Landscape

29
Total Assays
155
Tested Compounds
2
Assay Types
Binding — 26 assays, 155 compounds
BAO Format Assays Compounds Avg pChEMBL
protein format 12 85 6.0
tissue-based format 5 38 5.7
organism-based format 4 10 5.3
microsome format 3 1 6.0
assay format 1 0
cell-based format 1 21 5.0
Functional — 3 assays, 1 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 2 1 7.9
microsome format 1 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine